Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral dexamethasone for multiple sclerosis exacerbations
NL-OMON22907Phase 4Withdrawn
- Sponsor
- University Medical Center Groningen
- Start
- Aug 2006
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in multiple sclerosis (MS) comparing Oral dexamethasone with Placebo (2 arms). Primary endpoint: Clinical improvement on day 6. Planned start Aug 2006; status: withdrawn.
02
Drugs
dexamethasone
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NL-OMON22907.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON22907.